EARS News and Press, Auris Medical Holding AG From 06/21/21

Penny Stocks To Watch Before July The markets were smacked last week, which took many stocks lower. But for penny stocks, it was a much different story. If you’re new to this world of lower-priced stocks, you’ll likely be familiar with this trend. Even with the S&P, Do...

Treatment with OligoPhore TM siRNA stops aggressive ATLL tumor growth to near zero Significant reduction in tumor size, spleen size and peripheral blood lymphocyte counts Results add to extensive body of evidence for effective OligoPhore TM enabled delivery of nucleic acid...

The following slide deck was published by Auris Medical Holding Ltd. in conjunction with this event. For further details see: Auris Medical Holding (EARS) Presents At LD Micro Invitational XI Conference - Slideshow

Jiuzi Holdings (JZXN) +49%.GTT Communications (GTT) +28%.Community Bankers Trust Corporation (ESXB) +26% on merger agreement with United Bankshares.Tellurian (TELL) +26% on 10-year LNG sales deal with Vitol.Workhorse Group (WKHS) +16%.Auris Medical Holding (EARS) +14%.Blac...

Auris Medical Holding (EARS) jumps 10% premarket after acquiring privately held Trasir Therapeutics, based in Tampa, FL.The purchase price comprises 0.77M common shares of the acquiring Company, the assumption of certain selling shareholders’ cash outlays as well as a future ...

Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc. Trasir’s innovative peptide-based OligoPhore TM platform designed to enable extrahepatic delivery of oligonucleotides Trasir’s founder, Dr. Samuel Wickline, joining leadersh...

Auris Medical Holding (EARS) announces that its affiliate Altamira Medica has started preparations to conduct a study with its Bentrio nasal spray for protection against airborne viruses and allergens in India.The study will seek to evaluate the efficacy of Bentrio in...

Hamilton, Bermuda, June 1, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergology, today announced that its affiliate Altamira Medica Ltd. has...

Hamilton, Bermuda, May 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced that Chairman and CEO Thomas ...

Meeting essential requirements for marketing Bentrio TM in Europe under CE mark On track for first product launch in Europe towards end of Q2 2021 Hamilton, Bermuda, May 25, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to develo...